Jean-Philippe Combal, Pharm.D., Ph.D from Paris University is Co-Founder and Chief Executive Officer at Vivet Therapeutics, a company dedicated to developing innovative gene therapy treatments for orphan diseases. Previously Chief Operating Officer at GenSight Biologics, a clinical stage gene therapy company for treating blindness. He has been managing preclinical and clinical product and portfolio development in Ophthalmology at Fovea Pharmaceuticals/Sanofi serving as Vice President, Director of Development at Fovea, and then held the position of Vice President, Strategic Marketing for the Ophthalmic Division at Sanofi. Jean-Philippe’s expertise reside in defining, developing new & innovative drugs for various therapeutic indications including more recently ophthalmology and previously dermatology et Galderma International S.A. as Strategic Therapeutic Area leader. The synergy of global drug & strategic marketing development combined with business experience bring value for portfolio development of our technologies in various therapeutic area analyses.